Mirum Pharmaceuticals, Inc.: 10-Q filed 2025-11-04
What Mirum Pharmaceuticals, Inc. reported in its quarterly report filed 2025-11-04 (fiscal Q3 2025): 48 published measures, 138 facts as tagged in accession 0001759425-25-000054.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-11-04
- Fiscal period
- fiscal Q3 2025
- Accession
- 0001759425-25-000054 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Mirum Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 785,115,000 | USD | |
| At 2024-12-31 | 670,754,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 493,069,000 | USD | |
| At 2024-12-31 | 445,114,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 292,046,000 | USD | |
| At 2025-06-30 | 255,158,000 | USD | |
| At 2025-03-31 | 233,256,000 | USD | |
| At 2024-12-31 | 225,640,000 | USD | |
| At 2024-09-30 | 232,024,000 | USD | |
| At 2024-06-30 | 228,988,000 | USD | |
| At 2024-03-31 | 234,603,000 | USD | |
| At 2023-12-31 | 248,670,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 282,021,000 | USD | |
| At 2024-12-31 | 222,503,000 | USD | |
| At 2024-09-30 | 222,969,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,905,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -17,633,000 | USD | 273 |
| 2025-04-01 to 2025-06-30 | -5,861,000 | USD | 91 |
| 2025-01-01 to 2025-03-31 | -14,677,000 | USD | 90 |
| 2024-07-01 to 2024-09-30 | -14,235,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -64,152,000 | USD | 274 |
| 2024-04-01 to 2024-06-30 | -24,638,000 | USD | 91 |
| 2024-01-01 to 2024-03-31 | -25,279,000 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 49,760,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 15,393,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 354,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 973,000 | USD | 274 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 133,010,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 372,380,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 90,377,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 237,474,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 31,143,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 12,359,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -24,960,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -90,766,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -661,814,000 | USD | |
| At 2024-12-31 | -644,181,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 50,639,231 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 49,758,104 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 47,782,619 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 47,316,789 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 56,993,841 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 49,758,104 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 47,782,619 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 47,316,789 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 0.06 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | -0.35 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | -0.3 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.36 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 0.05 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | -0.35 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | -0.3 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.36 | USD/shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -262,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 1,169,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 347,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 1,606,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,277,000 | USD | |
| At 2024-12-31 | 1,139,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 52,398,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 35,193,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,603,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -17,569,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -12,684,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -63,384,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 530,575,000 | USD | |
| At 2024-12-31 | 392,788,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 160,359,000 | USD | |
| At 2024-12-31 | 126,551,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 12,167,000 | USD | |
| At 2024-12-31 | 14,618,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 231,895,000 | USD | |
| At 2024-12-31 | 249,819,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 107,132,000 | USD | |
| At 2024-12-31 | 78,286,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 130,407,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 389,949,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 103,061,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 300,858,000 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 24,021,000 | USD | |
| At 2024-12-31 | 22,403,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 61,910,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 182,902,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 50,545,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 145,391,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 51,314,176 | shares | |
| At 2024-12-31 | 48,338,096 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 37,000 | USD | |
| At 2024-12-31 | -373,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 8,500,000 | USD | |
| At 2024-12-31 | 8,675,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 9,396,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 231,895,000 | USD | |
| At 2024-12-31 | 249,819,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 9,918,000 | USD | |
| At 2024-12-31 | 5,382,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 15,981,000 | USD | |
| At 2024-12-31 | 2,509,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 23,874,000 | USD | |
| At 2024-12-31 | 11,784,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,643,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -16,464,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -13,888,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -62,546,000 | USD | 274 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -17,633,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -64,152,000 | USD | 274 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,590,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -17,223,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -12,838,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -64,876,000 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,905,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -17,633,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -14,235,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -64,152,000 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 18,170,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 17,573,000 | USD | 274 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 6,000,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 17,900,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 5,900,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 17,100,000 | USD | 274 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 3,606,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 10,791,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 3,586,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 10,732,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 395,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 2,589,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -1,087,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 982,000 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 6,325,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 6,325,000 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 2,151,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 771,000 | USD | 274 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 1,904,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 881,000 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 29,047,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 562,000 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 6,166,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 2,952,000 | USD | 274 |
Inspect the source
- Entity
- Mirum Pharmaceuticals, Inc. / CIK 0001759425
- Captured
- 2026-09-21T17:29:38.934Z
- SEC response SHA-256
59bc8f37f77ef3a1713f2e760e85eb8f6c60e92c1e3812c5856da34901351ce8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001759425.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))